PDCD1 and cancer: We have recently observed the frequency of peripheral CD107+ CD8+ cytotoxic T cells directed against a known cancer testis antigen in repeated longitudinal peripheral blood sampling of a gastric cancer patient treated by an anti-PD-1 to closely correlate with different phases of disease evolution under treatment [131].